Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.3 USD
-0.26%
Market Closed
Updated:
May 12, 2024
Taro Pharmaceutical Industries Ltd
EPS (Diluted)
|
Taro Pharmaceutical Industries Ltd
EPS (Diluted) Peer Comparison
Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
EPS (Diluted)
$1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-16%
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
EPS (Diluted)
$0
|
CAGR 3-Years
48%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
EPS (Diluted)
₪0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
EPS (Diluted)
$0
|
CAGR 3-Years
32%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
20%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
EPS (Diluted)
₪0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
EPS (Diluted)
₪0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's EPS (Diluted)?
EPS (Diluted)
1.2
USD
1.2
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's EPS (Diluted) amounts to 1.2 USD.
What is Taro Pharmaceutical Industries Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-16%
-16%
Over the last year, the EPS (Diluted) growth was 0%.
You don't have any saved screeners yet
